About this Journal Submit a Manuscript Table of Contents
Evidence-Based Complementary and Alternative Medicine
Volume 2013 (2013), Article ID 824120, 10 pages
http://dx.doi.org/10.1155/2013/824120
Research Article

Administration of Glucosylceramide Ameliorated the Memory Impairment in Aged Mice

1Department of Neuroscience and TIDRC, School of Medicine, Ewha Womans University, Seoul 158-710, Republic of Korea
2Institute of Life Science Research, Rexgene Biotech, Ochang, Chungbuk 363-883, Republic of Korea
3Advanced Institutes of Convergence Technology, Doosan Corporation, Glonet BG Biotech Division, Suwon, Gyeonggi-Do 443-270, Republic of Korea

Received 23 October 2012; Accepted 6 March 2013

Academic Editor: Seung-Heon Hong

Copyright © 2013 Yeonju Lee et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Saebyeol, N. Ryan, and W. Rodney, “Luteolin inhibits microglia and alters hippocampal-dependent spatial working memory in aged mice,” Journal of Nutrition, vol. 140, no. 10, pp. 1892–1898, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. D. A. Drachman, “Aging of the brain, entropy, and Alzheimer disease,” Neurology, vol. 67, no. 8, pp. 1340–1352, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. B. A. Yankner, T. Lu, and P. Loerch, “The aging brain,” Annual Review of Pathology, vol. 3, pp. 41–66, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Ruth, G. Matthew, R. Linda, and F. Steven, “Aging-related changes in neuroimmune-endocrine function: implications for hippocampal-dependent cognition,” Hormones and Behavior, vol. 62, no. 3, pp. 219–227, 2012.
  5. W. J. Streit, R. E. Mrak, and W. S. T. Griffin, “Microglia and neuroinflammation: a pathological perspective,” Journal of Neuroinflammation, vol. 1, no. 1, article 14, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Franceschi, S. Valensin, F. Lescai et al., “Neuroinflammation and the genetics of Alzheimer's disease: the search for a pro-inflammatory phenotype,” Aging, vol. 13, no. 3, pp. 163–170, 2001. View at Scopus
  7. J. Rogers, J. Luber-Narod, S. D. Styren, and W. H. Civin, “Expression of immune system-associated antigens by cells of the human central nervous system: relationship to the pathology of Alzheimer's disease,” Neurobiology of Aging, vol. 9, no. 4, pp. 339–349, 1988. View at Scopus
  8. G. Zuliani, M. Ranzini, G. Guerra et al., “Plasma cytokines profile in older subjects with late onset Alzheimer's disease or vascular dementia,” Journal of Psychiatric Research, vol. 41, no. 8, pp. 686–693, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Meunier, J. Ieni, and T. Maurice, “The anti-amnesic and neuroprotective effects of donepezil against amyloid β2535 peptide-induced toxicity in mice involve an interaction with the σ1 receptor,” British Journal of Pharmacology, vol. 149, no. 8, pp. 998–1012, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. E. I. Posse de Chaves, “Sphingolipids in apoptosis, survival and regeneration in the nervous system,” Biochimica et Biophysica Acta, vol. 1758, no. 12, pp. 1995–2015, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Spiegel and S. Milstien, “Sphingosine-1-phosphate: an enigmatic signalling lipid,” Nature Reviews Molecular Cell Biology, vol. 4, no. 5, pp. 397–407, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Gomez-Brouchet, D. Pchejetski, L. Brizuela et al., “Critical role for sphingosine kinase-1 in regulating survival of neuroblastoma cells exposed to amyloid-β peptide,” Molecular Pharmacology, vol. 72, no. 2, pp. 341–349, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. J. C. Jung, Y. J. Lee, S. H. Moon, J. H. Ryu, and S. Oh, “Phytoceramide shows neuroprotection and ameliorates scopolamine-induced memory impairment,” Molecules, vol. 16, no. 11, pp. 9090–9100, 2011.
  14. T. Sugawara and T. Miyazawa, “Separation and determination of glycolipids from edible plant sources by high-performance liquid chromatography and evaporative light-scattering detection,” Lipids, vol. 34, no. 11, pp. 1231–1237, 1999. View at Scopus
  15. K. Tsuji, S. Mitsutake, J. Ishikawa et al., “Dietary glucosylceramide improves skin barrier function in hairless mice,” Journal of Dermatological Science, vol. 44, no. 2, pp. 101–107, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. K. Fukunaga, M. Yoshida, F. Nakajima et al., “Design, synthesis, and evaluation of β-galactosylceramide mimics promoting β-glucocerebrosidase activity in keratinocytes,” Bioorganic and Medicinal Chemistry Letters, vol. 13, no. 5, pp. 813–815, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Yeom, S. H. Kim, B. Lee, et al., “Oral administration of glucosylcermide ameliorates inflammatory dry-skin condition in chronic oxazolone-induced irritant contact dermatitis in mouse ear,” Journal of Dermatological Science, vol. 67, no. 2, pp. 101–110, 2012.
  18. M. Gallagher, R. Burwell, and M. Burchinal, “Severity of spatial learning impairment in aging: development of a learning index for performance in the morris water maze,” Behavioral Neuroscience, vol. 107, no. 4, pp. 618–626, 1993. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Morris, “Developments of a water-maze procedure for studying spatial learning in the rat,” Journal of Neuroscience Methods, vol. 11, no. 1, pp. 47–60, 1984. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Blokland, E. Geraerts, and M. Been, “A detailed analysis of rats' spatial memory in a probe trial of a Morris task,” Behavioural Brain Research, vol. 154, no. 1, pp. 71–75, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. P. J. Modrego, M. A. Pina, and F. J. Lerín, “The impact of ageing on stroke subtypes, length of stay and mortality: study in the province of Teruel, Spain,” Acta Neurologica Scandinavica, vol. 108, no. 6, pp. 435–442, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. G. Saposnik, R. Cote, S. Phillips et al., “Stroke outcome in those over 80: a multicenter cohort study across Canada,” Stroke, vol. 39, no. 8, pp. 2310–2317, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. I. Kadish, O. Thibault, E. M. Blalock et al., “Hippocampal and cognitive aging across the lifespan: a bioenergetic shift precedes and increased cholesterol trafficking parallels memory impairment,” Journal of Neuroscience, vol. 29, no. 6, pp. 1805–1816, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Wei, H. Xu, J. L. Davies, and G. P. Hemmings, “Increase of plasma IL-6 concentration with age in healthy subjects,” Life Sciences, vol. 51, no. 25, pp. 1953–1956, 1992. View at Publisher · View at Google Scholar · View at Scopus
  25. R. A. Daynes, B. A. Araneo, W. B. Ershler, C. Maloney, G. Z. Li, and S. Y. Ryu, “Altered regulation of IL-6 production with normal aging: possible linkage to the age-associated decline in dehydroepiandrosterone and its sulfated derivative,” Journal of Immunology, vol. 150, no. 12, pp. 5219–5230, 1993. View at Scopus
  26. S. Amor, F. Puentes, D. Baker, and P. van der Valk, “Inflammation in neurodegenerative diseases,” Immunology, vol. 129, no. 2, pp. 154–169, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. B. E. Flanary, N. W. Sammons, C. Nguyen, D. Walker, and W. J. Streit, “Evidence that aging and amyloid promote microglial cell senescence,” Rejuvenation Research, vol. 10, no. 1, pp. 61–74, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. W. J. Streit, K. R. Miller, K. O. Lopes, and E. Njie, “Microglial degeneration in the aging brain—bad news for neurons?” Frontiers in Bioscience, vol. 13, no. 9, pp. 3423–3438, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. X. G. Luo, J. Q. Ding, and S. D. Chen, “Microglia in the aging brain: relevance to neurodegeneration,” Molecular Neurodegeneration, vol. 5, p. 12, 2010.
  30. T. Inamizu, M. P. Chang, and T. Makinodan, “Influence of age on the production and regulation of interleukin-1 in mice,” Immunology, vol. 55, no. 3, pp. 447–455, 1985. View at Scopus
  31. J. G. Sheng, R. E. Mrak, and W. S. T. Griffin, “Enlarged and phagocytic, but not primed, interleukin-1α-immunoreactive microglia increase with age in normal human brain,” Acta Neuropathologica, vol. 95, no. 3, pp. 229–234, 1998. View at Publisher · View at Google Scholar · View at Scopus
  32. S. M. Ye and R. W. Johnson, “An age-related decline in interleukin-10 may contribute to the increased expression of interleukin-6 in brain of aged mice,” NeuroImmunoModulation, vol. 9, no. 4, pp. 183–192, 2001. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Sierra, A. C. Gottfried-Blackmore, B. S. Mcewen, and K. Bulloch, “Microglia derived from aging mice exhibit an altered inflammatory profile,” GLIA, vol. 55, no. 4, pp. 412–424, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. E. G. Njie, E. Boelen, F. R. Stassen, H. W. Steinbusch, D. R. Borchelt, and W. J. Streit, “Ex vivo cultures of microglia from young and aged rodent brain reveal age-related changes in microglial function,” Neurobiology of Aging, vol. 33, no. 1, pp. 195.e1–195.e12, 2010.
  35. V. H. Perry, M. K. Matyszak, and S. Fearn, “Altered antigen expression of microglia in the aged rodent CNS,” GLIA, vol. 7, no. 1, pp. 60–67, 1993. View at Scopus
  36. L. G. Sheffield and N. E. J. Berman, “Microglial expression of MHC class II increases in normal aging of nonhuman primates,” Neurobiology of Aging, vol. 19, no. 1, pp. 47–55, 1998. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Kullberg, H. Aldskogius, and B. Ulfhake, “Microglial activation, emergence of ED1-expressing cells and clusterin upregulation in the aging rat CNS, with special reference to the spinal cord,” Brain Research, vol. 899, no. 1-2, pp. 169–186, 2001. View at Publisher · View at Google Scholar · View at Scopus
  38. T. Chan-Ling, S. Hughes, L. Baxter et al., “Inflammation and breakdown of the blood-retinal barrier during “physiological aging” in the rat retina: a model for CNS aging,” Microcirculation, vol. 14, no. 1, pp. 63–76, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. N. L. Sparkman, J. B. Buchanan, J. R. R. Heyen, J. Chen, J. L. Beverly, and R. W. Johnson, “Interleukin-6 facilitates lipopolysaccharide-induced disruption in working memory and expression of other proinflammatory cytokines in hippocampal neuronal cell layers,” Journal of Neuroscience, vol. 26, no. 42, pp. 10709–10716, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Blokland, E. Geraerts, and M. Been, “A detailed analysis of rats' spatial memory in a probe trial of a Morris task,” Behavioural Brain Research, vol. 154, no. 1, pp. 71–75, 2004. View at Publisher · View at Google Scholar · View at Scopus
  41. Y. A. Hannun, “The sphingomyelin cycle and the second messenger function of ceramide,” Journal of Biological Chemistry, vol. 269, no. 5, pp. 3125–3128, 1994. View at Scopus
  42. N. Tang, W. Y. Ong, E. M. Zhang, P. Chen, and J. F. Yeo, “Differential effects of ceramide species on exocytosis in rat PC12 cells,” Experimental Brain Research, vol. 183, no. 2, pp. 241–247, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. S. Cuzzocrea, R. Di Paola, T. Genovese et al., “Anti-inflammatory and anti-apoptotic effects of fumonisin B1, an inhibitor of ceramide synthase, in a rodent model of splanchnic ischemia and reperfusion injury,” Journal of Pharmacology and Experimental Therapeutics, vol. 327, no. 1, pp. 45–57, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. P. Gangoiti, M. H. Granado, S. W. Wang, J. Y. Kong, U. P. Steinbrecher, and A. Gomez-Munoz, “Ceramide 1-phosphate stimulates macrophage proliferation through activation of the PI3-kinase/PKB, JNK and ERK1/2 pathways,” Cellular Signalling, vol. 20, no. 4, pp. 726–736, 2008. View at Publisher · View at Google Scholar · View at Scopus
  45. J. Mitoma, M. Ito, S. Furaya, and Y. Hirabayashi, “Bipotential roles of ceramide in the growth of hippocampal neurons: promotion of cell survival and dendritic outgrowth in dose- and developmental stage-dependent manners,” Journal of Neuroscience Research, vol. 51, no. 6, pp. 712–722, 1998.
  46. F. Irie and Y. Hirabayashi, “Ceramide prevents motoneuronal cell death through inhibition of oxidative signal,” Neuroscience Research, vol. 35, no. 2, pp. 135–144, 1999. View at Publisher · View at Google Scholar · View at Scopus
  47. I. Murakami, Y. Wakasa, S. Yamashita, et al., “Phytoceramide and sphingoid bases derived from brewer’s yeast Saccharomyces pastorianus activate peroxisome proliferator-activated receptors,” Lipids in Health and Disease, vol. 10, no. 150, pp. 1–11, 2011.